NSW to trial pill testing The State Government says its decision to greenlight a 12-month trial at festivals is based on advice from experts and those with lived experience.
Australia’s new leading contributor to burden of disease Smoking tobacco has been overtaken by overweight and obesity as the leading modifiable risk factor, according to a new report.
RACGP calls for GP permission to provide diabetes technology access As part of a consultation process for subsidised access to continuous glucose monitoring, the college says GPs are ‘essential’ to supporting equitable access.
Australian-first STI self-test receives TGA approval The test for chlamydia and gonorrhoea could result in timelier diagnosis, but are there implications of doing so outside the healthcare setting?
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Bowel cancer screening rates down Though participation in screening has dropped, wait times for colonoscopy referrals are in excess of the recommended 30-day timeframe.
TGA’s vaping crackdown a sign of things to come The medicines regulator issued infringement notices to four entities this week, totalling almost $600,000.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
RACGP moves to shore up wavering support for 60-day dispensing Amid reports of crossbenchers becoming wary of the reform, the college has co-signed an open letter outlining the expected benefits for both patients and the primary care system.
‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.